Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 7% | |
| GABAergic neuron | 4 studies | 32% ± 15% | |
| interneuron | 4 studies | 37% ± 23% | |
| glutamatergic neuron | 3 studies | 44% ± 22% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 10% | |
| dendritic cell | 3 studies | 24% ± 4% | |
| endothelial cell | 3 studies | 25% ± 5% | |
| oligodendrocyte | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 702.86 | 1445 / 1445 | 100% | 3.70 | 183 / 183 |
| ovary | 100% | 1257.59 | 180 / 180 | 100% | 4.31 | 430 / 430 |
| prostate | 100% | 984.09 | 245 / 245 | 100% | 5.00 | 502 / 502 |
| breast | 100% | 1099.83 | 459 / 459 | 100% | 4.92 | 1116 / 1118 |
| brain | 100% | 1027.79 | 2641 / 2642 | 100% | 4.37 | 704 / 705 |
| stomach | 100% | 607.86 | 359 / 359 | 100% | 3.41 | 285 / 286 |
| uterus | 100% | 1052.14 | 170 / 170 | 100% | 3.68 | 457 / 459 |
| thymus | 100% | 1146.00 | 653 / 653 | 100% | 4.52 | 602 / 605 |
| lung | 100% | 770.47 | 576 / 578 | 99% | 3.21 | 1146 / 1155 |
| pancreas | 100% | 527.46 | 328 / 328 | 98% | 3.08 | 175 / 178 |
| intestine | 100% | 786.27 | 966 / 966 | 98% | 3.30 | 518 / 527 |
| bladder | 100% | 783.90 | 21 / 21 | 97% | 3.05 | 489 / 504 |
| kidney | 100% | 869.37 | 89 / 89 | 96% | 3.24 | 864 / 901 |
| adrenal gland | 100% | 733.19 | 258 / 258 | 95% | 3.86 | 219 / 230 |
| liver | 100% | 535.20 | 226 / 226 | 91% | 2.10 | 368 / 406 |
| skin | 100% | 1048.88 | 1807 / 1809 | 79% | 1.92 | 374 / 472 |
| adipose | 100% | 959.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 2.88 | 29 / 29 |
| spleen | 100% | 812.68 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.10 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.53 | 1 / 1 |
| blood vessel | 100% | 854.38 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 520.00 | 798 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 536.43 | 849 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 61% | 1.26 | 49 / 80 |
| peripheral blood | 48% | 406.51 | 445 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0018022 | Biological process | peptidyl-lysine methylation |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0042054 | Molecular function | histone methyltransferase activity |
| GO_0008168 | Molecular function | methyltransferase activity |
| GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
| Gene name | EEF1AKMT2 |
| Protein name | EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase METTL10) EEF1A lysine methyltransferase 2 METTL10 protein |
| Synonyms | METTL10 C10orf138 hCG_1818511 |
| Description | FUNCTION: Protein-lysine methyltransferase that selectively catalyzes the trimethylation of EEF1A at 'Lys-318'. . FUNCTION: Protein-lysine methyltransferase that selectively catalyzes the trimethylation of EEF1A at 'Lys-318'. . |
| Accessions | G3V238 ENST00000652548.2 A0A494BZY7 Q8TC28 ENST00000464099.5 ENST00000495711.2 M0QZ67 Q5JPI9 ENST00000466270.5 ENST00000368836.7 |
